Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a ...
Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering ...
The Kenya Union of Clinical Officers, the Ministry of Health and the Council of Governors on Wednesday signed a return-to-work agreement.
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Africa has seen a sharp rise in public health events, increasing from 152 in 2022 to 213 in 2024, highlighting ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...
Kenya has called for enhanced global collaboration in tackling the misuse of controlled substances, urging further evaluation ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback